339 related articles for article (PubMed ID: 16432513)
1. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.
Kawano T; Anrather J; Zhou P; Park L; Wang G; Frys KA; Kunz A; Cho S; Orio M; Iadecola C
Nat Med; 2006 Feb; 12(2):225-9. PubMed ID: 16432513
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage.
Ahmad AS; Saleem S; Ahmad M; Doré S
Toxicol Sci; 2006 Jan; 89(1):265-70. PubMed ID: 16237196
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signaling induces cyclooxygenase-1-dependent prostanoid synthesis in microglia: roles in the outcome of excitotoxic brain injury.
Anrather J; Gallo EF; Kawano T; Orio M; Abe T; Gooden C; Zhou P; Iadecola C
PLoS One; 2011; 6(10):e25916. PubMed ID: 22022466
[TBL] [Abstract][Full Text] [Related]
4. Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor.
Carlson NG; Rojas MA; Black JD; Redd JW; Hille J; Hill KE; Rose JW
J Neuroinflammation; 2009 Feb; 6():5. PubMed ID: 19222857
[TBL] [Abstract][Full Text] [Related]
5. The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death.
Carlson NG; Bellamkonda S; Schmidt L; Redd J; Huecksteadt T; Weber LM; Davis E; Wood B; Maruyama T; Rose JW
J Neuroinflammation; 2015 May; 12():101. PubMed ID: 25997851
[TBL] [Abstract][Full Text] [Related]
6. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice.
Saleem S; Li RC; Wei G; Doré S
J Neurosci Res; 2007 Aug; 85(11):2433-40. PubMed ID: 17600836
[TBL] [Abstract][Full Text] [Related]
7. Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation.
Ahmad AS; Yun YT; Ahmad M; Maruyama T; Doré S
Neurotox Res; 2008 Dec; 14(4):343-51. PubMed ID: 19073437
[TBL] [Abstract][Full Text] [Related]
8. The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection.
Gendron TF; Brunette E; Tauskela JS; Morley P
Eur J Pharmacol; 2005 Jul; 517(1-2):17-27. PubMed ID: 15964567
[TBL] [Abstract][Full Text] [Related]
9. Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors.
Ikeda-Matsuo Y; Tanji H; Ota A; Hirayama Y; Uematsu S; Akira S; Sasaki Y
Br J Pharmacol; 2010 Jun; 160(4):847-59. PubMed ID: 20590584
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II.
Capone C; Faraco G; Anrather J; Zhou P; Iadecola C
Hypertension; 2010 Apr; 55(4):911-7. PubMed ID: 20194308
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.
Vinukonda G; Csiszar A; Hu F; Dummula K; Pandey NK; Zia MT; Ferreri NR; Ungvari Z; LaGamma EF; Ballabh P
Brain; 2010 Aug; 133(Pt 8):2264-80. PubMed ID: 20488889
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.
McCullough L; Wu L; Haughey N; Liang X; Hand T; Wang Q; Breyer RM; Andreasson K
J Neurosci; 2004 Jan; 24(1):257-68. PubMed ID: 14715958
[TBL] [Abstract][Full Text] [Related]
13. Involvement of prostaglandin E receptor EP3 subtype and prostacyclin IP receptor in decreased acid response in damaged stomach.
Nishio H; Terashima S; Nakashima M; Aihara E; Takeuchi K
J Physiol Pharmacol; 2007 Sep; 58(3):407-21. PubMed ID: 17928639
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic.
Abe T; Kunz A; Shimamura M; Zhou P; Anrather J; Iadecola C
J Cereb Blood Flow Metab; 2009 Jan; 29(1):66-72. PubMed ID: 18648380
[TBL] [Abstract][Full Text] [Related]
15. PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
Zhen G; Kim YT; Li RC; Yocum J; Kapoor N; Langer J; Dobrowolski P; Maruyama T; Narumiya S; Doré S
Neurobiol Aging; 2012 Sep; 33(9):2215-9. PubMed ID: 22015313
[TBL] [Abstract][Full Text] [Related]
16. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes.
Matsuoka Y; Furuyashiki T; Bito H; Ushikubi F; Tanaka Y; Kobayashi T; Muro S; Satoh N; Kayahara T; Higashi M; Mizoguchi A; Shichi H; Fukuda Y; Nakao K; Narumiya S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4132-7. PubMed ID: 12642666
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E receptors as targets for ischemic stroke: Novel evidence and molecular mechanisms of efficacy.
Li L; Sluter MN; Yu Y; Jiang J
Pharmacol Res; 2021 Jan; 163():105238. PubMed ID: 33053444
[TBL] [Abstract][Full Text] [Related]
18. Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.
Saleem S; Kim YT; Maruyama T; Narumiya S; Doré S
J Neuroimmunol; 2009 Mar; 208(1-2):87-93. PubMed ID: 19203800
[TBL] [Abstract][Full Text] [Related]
19. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice.
Takeuchi K; Araki H; Umeda M; Komoike Y; Suzuki K
J Pharmacol Exp Ther; 2001 Jun; 297(3):1160-5. PubMed ID: 11356942
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway.
Zhou P; Qian L; Chou T; Iadecola C
Neurobiol Dis; 2008 Mar; 29(3):543-51. PubMed ID: 18178094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
